Corebridge Financial Inc. Trims Position in AdaptHealth Corp. (NASDAQ:AHCO)

Corebridge Financial Inc. trimmed its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 7.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 54,357 shares of the company’s stock after selling 4,227 shares during the period. Corebridge Financial Inc.’s holdings in AdaptHealth were worth $517,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Assetmark Inc. acquired a new position in AdaptHealth during the fourth quarter valued at $28,000. Blue Trust Inc. lifted its holdings in shares of AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after buying an additional 1,115 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after buying an additional 1,690 shares during the period. LRI Investments LLC boosted its stake in shares of AdaptHealth by 32.0% in the third quarter. LRI Investments LLC now owns 15,331 shares of the company’s stock worth $172,000 after buying an additional 3,713 shares during the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new stake in AdaptHealth during the fourth quarter worth about $169,000. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $9.00 on Wednesday. The company has a fifty day moving average of $9.95 and a two-hundred day moving average of $10.10. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90. The stock has a market capitalization of $1.21 billion, a PE ratio of -5.45, a P/E/G ratio of 1.08 and a beta of 1.44. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

Wall Street Analysts Forecast Growth

AHCO has been the topic of several recent research reports. UBS Group lowered their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Robert W. Baird increased their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. Truist Financial lifted their price objective on shares of AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Royal Bank of Canada increased their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Finally, Canaccord Genuity Group lifted their price target on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $13.80.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.